Shares of healthcare tec🥃hnology firm Tempus AI surged Fr꧂iday as they began trading on the Nasdaq.

Trading under the ticker symbol “TEM," Tempus AI shares opened at $40 each, $3 above their initial public offering (IPO) price. They jumped nearly 18% to $4𒉰3.64 at one point before fading to $38.30 as o𒐪f 2 p.m. ET, a rise of 3.5%.

The company sold 11.1 million shares in the IPO, and the $37-per-share price was at the high end of its target range of $35 to $37. Tempus said the sale raised $410.7 million.

Goog🦋le-Backed Tempus Uses AI to Process Medical Data

The company uses AI to analyze medical tests to help doctors better treat their patients. Alphabet’s (GOOGL) Google is among the investors in the firm.

Founder and 澳洲幸运5开奖号码历史查询:Chief Executive Officer (CEO) Eric Lefkofsky, who was also the founder of e-commerce marketplace Groupon (GRPN), told CNBC that while Tempus is still a money-losing business, it expects "sometime in 2025 to turn the corner and be both 澳洲幸运5开奖号码历史查询:cash flow positive and adjusted EBITDA positive.”